Correspondingly, downregulated expression was also observed in CRC tissues with WT KRAS (P < 0.05), but we did not find significant differences between the 2 groups of CRC tissues with KRAS mutation and WT KRAS (Figure 1, C and D). This evidence concerns the gene KRAS and colorectal carcinoma.